Drug discovery and Development
The primary objective of toxicology studies in the drug development process is to evaluate the safety of potential drug candidates. This is accomplished using relevant animal models and validated procedures. The ultimate goal is to translate the animal model responses into an understanding of the risk for human subjects. To this end, the toxicologist must be aware of the international guidelines for safety evaluation, as well as traditional and non-traditional toxicology models.
- Pre-clinical trials |Animal methods
- Clinical Trials
- In vitro-studies
- In vivo studies
- Pharmacovigilance
Related Conference of Drug discovery and Development
November 27-28, 2025
7th International Conference on Clinical Pharmacology and Toxicology
Zurich, Switzerland
February 26-27, 2026
9th International Conference on Global Toxicology and Risk Assessment
Paris, France
Drug discovery and Development Conference Speakers
Recommended Sessions
- Advances in Pharmacology
- Analytical Toxicology
- Biochemical and Molecular Toxicology
- Biomedical Toxicology
- Clinical Pharmacology
- Clinical Toxicology
- Drug discovery and Development
- Excitotoxicity
- Food Safety and Environmental Toxicity
- Forensic Toxicology
- Genetic Toxicology
- Inhalation Toxicology
- Medical Toxicology
- Neuro Toxicology
- Organ Toxicology
- Paediatric Toxicology
- Pharmacological Testing
- Pharmacology
- Pharmacy and Pharmaceutical Technology
- Recent Advances in Pharmacology and Toxicology
- Toxicity Testing
- Toxicology
- Toxicology and Risk Assessment
- Toxicology Applications
- Toxicology issues related to covid -19
- Toxicology Methods and Mechanisms
Related Journals
Are you interested in
- Adverse Drug Reactions and Pharmacovigilance - clinical pharmacology 2025 (Switzerland)
- Cardiovascular Pharmacology - clinical pharmacology 2025 (Switzerland)
- Clinical Toxicology of Drugs of Abuse - clinical pharmacology 2025 (Switzerland)
- Clinical Trials and Regulatory Affairs - clinical pharmacology 2025 (Switzerland)
- Drug Interactions and Polypharmacy - clinical pharmacology 2025 (Switzerland)
- Emerging Trends in Clinical Pharmacology - clinical pharmacology 2025 (Switzerland)
- Environmental and Occupational Toxicology - clinical pharmacology 2025 (Switzerland)
- Future Directions in Clinical Pharmacology and Toxicology - clinical pharmacology 2025 (Switzerland)
- Innovations in Drug Development and Therapeutics - clinical pharmacology 2025 (Switzerland)
- Natural Products and Toxicology - clinical pharmacology 2025 (Switzerland)
- Neuropharmacology and Toxicology - clinical pharmacology 2025 (Switzerland)
- Pediatric and Geriatric Pharmacology - clinical pharmacology 2025 (Switzerland)
- Pharmacogenomics and Personalized Medicine - clinical pharmacology 2025 (Switzerland)
- Pharmacokinetics and Pharmacodynamics - clinical pharmacology 2025 (Switzerland)
- Toxicology and Risk Assessment - clinical pharmacology 2025 (Switzerland)

